Powered Morcellators Market Analysis | United States | 2017-2023 | MedCore

Powered Morcellators Market Analysis | United States | 2017-2023 | MedCore


Laparoscopic morcellators are targeted towards three categories of minimally invasive surgery (MIS): general surgery, urology surgery and most commonly in gynecological surgery. Traditionally, laparoscopic resection devices are employed to excise malignant tissue masses from site of operation; however, with the reduction in the size of laparoscopic instruments used in MIS, removal of large-mass malignant tissues by way of small incisions can be cumbersome.

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 9/1/2017
  • Pages: 132
  • Type: MedCore

The massive decrease in morcellator sales in 2017 will not extend to upcoming years, unless the FDA decides to take further action. At this point, further FDA action seems unlikely. Most hospitals and surgeons have already made their decision to continue to morcellate or not, based on the evidence at hand. The remaining install base of hospitals that have chosen to continue morcellating will continue to do so in the future. So, following the steep decline in 2016, the powered morcellator market is expected to resume characteristic unit sales growth.

Laparoscopic morcellators are tubular in shape, 12 mm to 20 mm in diameter, and equipped with a hand piece and a blade. During a laparoscopy procedure, the morcellator is inserted through an incision in the abdominal area to access the detached tissue mass. Graspers are usually inserted into the hollow center of the morcellator to grasp the tissue firmly and feed it into the blade of the morcellator. This offers surgeons precision and control over the rate and degree of morcellation.

Segments Covered in This Market

  • Reusable Powered Mocellator Market
  • Reposable Powered Morcellator Market
  • Disposable Powered Morcellator Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

LiNA Medical developed its Xcise™ laparoscopic morcellator in 2010, which became available on the U.S. market early in 2011. The device is cordless, offering surgeons greater mobility during operation. Reviews from end-users have been positive regarding its weight. Karl Storz offers the benefit of a reposable device, such as its ROTOCUT™ G1 Morcellator and SAWALHE II SUPERCUT™, to price-conscious hospitals and clinics. These devices have disposable blades that ensure sharpness during surgery, and a reusable handle. In the ROTOCUT™ G1 Morcellator, the gears are mated with the blade as a single unit. Olympus Gyrus ACM was the first manufacturer to market a bladeless laparoscopic morcellator: the PKS™ PlasmaSORD.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled U.S. Market Report Suite for Laparoscopic Devices – MedSuite

Learn More about these product types

The "US Market Report Suite for Laparoscopic Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Karl Storz
Applied Medical
Richard Wolf
B. Braun Aesculap
C. R. Bard
Apollo Endoscopy
Microline Surgical
Cooper Surgical
Integra LifeSciences (Jarit)
Lina Medical
ReShape Medical
Obalon Therapeautics
Others include: Smith and Nephew, B.Braun/Aesculap, Cooper Surgical, Integra LifeSciences, Karl Storz, Olympus, Richard Wolf, Solos Endoscopy, Stryker, Surgiquest, Teleflex, Blue Endo, Cambridge Endo, Surgical Innovations, Cardinal Health, Bovie Medical, CareFusion, ERBE, Jarit, Megadyne, ThermoFisher, Cousin Biotech, Soring etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers